Trials that use: Non-inferiority trial design
New to this method? Read the tutorial →
894 results
- Primed vs. Unprimed rTMS in Chronic Stroke: Complete Statistical AnalysisIndependent statistical analysis of Primed vs. Unprimed rTMS in Chronic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01757821).
- PRINCEIndependent statistical analysis of PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Current Opioid-User Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PRIORITIIndependent statistical analysis of A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.: primary endpoint results,…
- Programmed Intermittent Bolus Dosing Versus Continuous Epidural Infusion for Epidural Analgesia in Abdominal Surgery.: Complete Statistical AnalysisIndependent statistical analysis of Programmed Intermittent Bolus Dosing Versus Continuous Epidural Infusion for Epidural Analgesia in Abdominal Surgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients: Complete Statistical AnalysisIndependent statistical analysis of Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PrometheusIndependent statistical analysis of Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Promiseb Topical Cream for Cradle Cap: Complete Statistical AnalysisIndependent statistical analysis of Promiseb Topical Cream for Cradle Cap: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01214434).
- Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children: Complete Statistical AnalysisIndependent statistical analysis of Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial: Complete Statistical AnalysisIndependent statistical analysis of Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02276885).
- PRONTO-T1DA detailed statistical analysis of the randomized phase 3 PRONTO-T1D trial of LY900014 in participants with type 1 diabetes, including HbA1c, postprandial glucose, non-inferiority, ANCOVA, mixed-effects modeling, and safety.
- PRONTO-T2DIndependent statistical analysis of A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A: Complete Statistical AnalysisIndependent statistical analysis of Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PROSELICAA detailed statistical analysis of the phase 3 PROSELICA trial comparing cabazitaxel 20 mg/m² with 25 mg/m² plus prednisone in metastatic castration resistant prostate cancer, including non-inferiority methodology, overall survival, progression endpoints,…
- ProspectIndependent statistical analysis of A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer: primary endpoint results, effect estimate with…
- Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses: Complete Statistical AnalysisIndependent statistical analysis of Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin): Complete Statistical AnalysisIndependent statistical analysis of Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PROTECtIndependent statistical analysis of A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00579995).
- Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PRP vs Corticosteroid in Baker’s Cyst: Complete Statistical AnalysisIndependent statistical analysis of PRP vs Corticosteroid in Baker's Cyst: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02249377).
- PuraBond PROOFIndependent statistical analysis of PuraBond® and Pain Following Resection of Oral or Oropharyngeal Mucosal Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PURSUEComplete statistical analysis of the PURSUE phase 3 trial of a single injection of SCH 900962 versus daily recFSH injections in women undergoing controlled ovarian stimulation for infertility, including non-inferiority methodology, efficacy…
- QuickOpt Chronic Study: Complete Statistical AnalysisIndependent statistical analysis of QuickOpt Chronic Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01172067).
- QUINCEIndependent statistical analysis of Ophthalmic Compatibility During Seven Days of Continuous Wear of Silicone Hydrogel Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Quit or Switch: E-cigarette Study: Complete Statistical AnalysisIndependent statistical analysis of Quit or Switch: E-cigarette Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05525078).
- QUORUMIndependent statistical analysis of Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RA-BRANCHIndependent statistical analysis of A Study of Baricitinib in Participants With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04086745).
- Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RadioCityIndependent statistical analysis of A Study of the Performance of Certain Prevail Implants Used in Short Fixed Cases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RAFAELOCALIndependent statistical analysis of Evaluation of the Value of Perianal Infiltration During Thermodestruction of Haemorrhoidal Disease by Radiofrequency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.: Complete Statistical AnalysisIndependent statistical analysis of Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.: primary endpoint results,…
- Randomized Controlled Trial of Group Prevention Coaching: Complete Statistical AnalysisIndependent statistical analysis of Randomized Controlled Trial of Group Prevention Coaching: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01838226).
- Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical: Complete Statistical AnalysisIndependent statistical analysis of Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP: Complete Statistical AnalysisIndependent statistical analysis of Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RasbAKIIndependent statistical analysis of Lowering Serum Uric Acid to Prevent Acute Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00756964).
- Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2: Complete Statistical AnalysisIndependent statistical analysis of Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02132767).
- Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy: Complete Statistical AnalysisIndependent statistical analysis of Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RDEBIndependent statistical analysis of A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare® Matrix) for Wound Healing in RDEB Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RE-COVER IComplete statistical analysis of RE-COVER I, the randomized phase 3 trial comparing dabigatran 150 mg with warfarin for 6 months in patients with acute symptomatic venous thromboembolism, including non-inferiority methodology, time-to-event analyses,…
- RE-MEDYA detailed statistical analysis of the randomized phase 3 RE-MEDY trial comparing dabigatran with warfarin for secondary prevention of venous thromboembolism, including time-to-event methodology, non-inferiority analysis, bleeding outcomes, and statistical interpretation.
- REALYSEIndependent statistical analysis of A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE): primary endpoint results, effect estimate with confidence…
- RECORDComplete statistical analysis of the RECORD phase 3 trial of rosiglitazone and cardiovascular outcomes in type 2 diabetes, including trial design, time-to-event endpoints, hazard ratios, confidence intervals, non-inferiority analysis, re-adjudication outcomes, safety,…
- Rectal Spacer for Prostate Cancer Radiation Image Guidance: Complete Statistical AnalysisIndependent statistical analysis of Rectal Spacer for Prostate Cancer Radiation Image Guidance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05650021).
- Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial: Complete Statistical AnalysisIndependent statistical analysis of Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00545181).
- REDUCEhfIndependent statistical analysis of Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reducing Pain of Lidocaine Injection: Complete Statistical AnalysisIndependent statistical analysis of Reducing Pain of Lidocaine Injection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02288364).
- Relative Bioavailability of of Olodaterol and Ketoconazole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of of Olodaterol and Ketoconazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01153711).